AMEFX
Price
$24.75
Change
-$0.13 (-0.52%)
Updated
Dec 17 closing price
CVTCX
Price
$52.15
Change
-$0.20 (-0.38%)
Updated
Dec 17 closing price
Ad is loading...

AMEFX vs CVTCX

Header iconAMEFX vs CVTCX Comparison
Open Charts AMEFX vs CVTCXBanner chart's image
American Funds Income Fund of Amer F2
Price$24.75
Change-$0.13 (-0.52%)
VolumeN/A
CapitalizationN/A
Calamos Growth & Income C
Price$52.15
Change-$0.20 (-0.38%)
VolumeN/A
CapitalizationN/A
AMEFX vs CVTCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMEFX vs. CVTCX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMEFX is a Buy and CVTCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
AMEFX has more cash in the bank: 123B vs. CVTCX (3.01B). AMEFX pays higher dividends than CVTCX: AMEFX (3.73) vs CVTCX (0.13). AMEFX was incepted earlier than CVTCX: AMEFX (16 years) vs CVTCX (28 years). AMEFX is a more actively managed with annual turnover of: 40.00 vs. CVTCX (20.00). AMEFX has a lower initial minimum investment than CVTCX: AMEFX (250) vs CVTCX (2500). CVTCX annual gain was more profitable for investors over the last year : 19.26 vs. AMEFX (10.88). CVTCX return over 5 years is better than : 51.81 vs. AMEFX (21.04).
AMEFXCVTCXAMEFX / CVTCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years28 years-
Gain YTD9.50822.79342%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets123B3.01B4,088%
Annual Yield % from dividends3.730.132,931%
Returns for 1 year10.8819.2657%
Returns for 3 years6.578.7375%
Returns for 5 years21.0451.8141%
Returns for 10 years33.7676.8544%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX56.303.32
+6.27%
MoonLake Immunotherapeutics
CVKD11.450.45
+4.09%
Cadrenal Therapeutics Inc
CMPX1.530.04
+2.68%
Compass Therapeutics
WAT373.72-0.29
-0.08%
Waters Corp
PSTX9.50-0.01
-0.11%
Poseida Therapeutics